Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00661_DB01396_nanopub.RA65CGbHW-XvGsSFdclW4DQXfpRq-hoF5vOT_mrVFGtXs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00661_DB01396 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00661_DB01396 label "DDI between Verapamil and Digitoxin - Verapamil may increase the serum concentration of Digitoxin by decreasing its metabolism and clearance. Monitor for changes in the therapeutic/adverse effects of Digitoxin if Verpamail is initiated, discontinued or dose changed. [drugbank_resource:DB00661_DB01396]" assertion.
- drugbank_resource:DB00661_DB01396 identifier "drugbank_resource:DB00661_DB01396" assertion.
- drugbank_resource:DB00661_DB01396 title "DDI between Verapamil and Digitoxin - Verapamil may increase the serum concentration of Digitoxin by decreasing its metabolism and clearance. Monitor for changes in the therapeutic/adverse effects of Digitoxin if Verpamail is initiated, discontinued or dose changed." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB01396 assertion.
- drugbank:DB01396 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB01396 assertion.